Modeling Patient Response to a Therapeutic Diet in Crohn's Disease (TDI)
is proposed randomized controlled trial (RCT) explores the efficacy of a Crohn's Disease (CD) Therapeutic Dietary Intervention (TDI) compared to conventional management (CM) to induce steroid-free clinical remission at week 13 in patients with active, mild-to-moderate luminal CD. For asymptomatic patients with active disease, efficacy of the diet will be explored by using fecal calprotectin and sonographic findings.
Sponsor: University of Calgary
Trial Type: Interventional
First Posted: Oct. 22, 2020